Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) had soared by 15.8% as of 12:06 p.m. ET on Friday. Did the clinical-stage ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...

Pharma stocks reacted sharply to concerns that the US might impose tariffs on pharmaceutical imports, causing the Nifty ...

We recently published a list of Shares of 10 Firms Soar on Friday. In this article, we are going to take a look at where ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CVS Health (CVS – Research Report) and ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) have received a consensus recommendation of “Buy” ...

West Pharmaceutical reported Q4 earnings and revenue above expectations but issued a weak 2025 forecast. William Blair ...

Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...

Donald Trump Jr. and Eric Trump are participating in Dominari Holdings' private placement and are joining its advisory board.